Global STD Diagnostics Market Size By Type (Chlamydia Testing, Gonorrhea Testing), By Location of Test (Laboratory Tests, Point of Care Tests), By Devices Type (Thermal Cyclers – PCR, Point Of Care (PoC) Devices), By End-User (Diagnostics Centers, Government Organizations), By Geography Scope And Forecast

STD Diagnostics Market Size And Forecast

STD Diagnostics Market size was valued at USD 99,844.86 Million in 2022 and is projected to reach USD 176,321.32 Million by 2030, growing at a CAGR of 7.46% from 2024 to 2030. 

The rising prevalence of STDs is the primary driver of the worldwide STD testing industry. The Global STD Diagnostics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global STD Diagnostics Market Executive Summary

A Sexually Transmitted Diseases (STDs) are sexually transmitted infections that are often contracted through intercourse, blood transfusions, the use of unsterilized medication needles, and mother-to-child transmission during delivery or breastfeeding. These diseases don’t have any symptoms and are identified by a variety of tests, such as blood, urine, or fluid samples. It can be done to cure STDs caused on by bacteria with the use of antibiotics and antiviral medications. Some of the instruments used to diagnose the disease include immunochromatographic tests, flow cytometers, and absorbance microplate readers and others.

The standards that society maintains for sexual behavior have changed significantly throughout time. The danger of spreading STDs has increased as a result of this alteration in sexual behavior, prompting more efforts in diagnosis. Also, the prevalence of STDs may be attributed to limited or inadequate sex education programs. There is an increased probability of transmission when people lack the information and abilities necessary to participate in safe sexual behavior.

The emergence of antibiotic-resistant strains of bacteria that because STDs is a growing concern. This necessitates more vigilant and widespread diagnostic efforts to promptly administer appropriate treatments. The expansion of diagnosis is crucial for monitoring the prevalence of antibiotic-resistant strains and adapting treatment strategies accordingly. In addition, Technological developments in medicine have entirely transformed the diagnosis of STDs. Infection detection has become more straightforward with quicker and more precise diagnostic instruments, such as point-of-care and nucleic acid amplification tests (NAATs). These instruments’ efficiency and accessibility have a significant impact on the growth of STD diagnosis by rendering infections easier to identify and treat for medical practitioners.

Global STD Diagnostics Market Attractiveness Analysis

The Global Sexually Transmitted Disease (STD) Diagnosis market is experiencing a scaled level of attractiveness in the North America region. The North America region has a prominent presence and holds the major share of the global market.   North America is anticipated to account for the significant market share of 36.92% by 2030.

North America dominates the global market for the diagnosis of STDs. The US is expected to be the largest market in the North American region because of the vast number of diagnostic firms and the rising awareness of illnesses. 41,655 of the 133,945 cases of syphilis that were recorded in 2020 were in the primary and secondary (P&S) phases of the illness, which are the most transmittable. Due to the increased demand for diagnostic procedures relevant to these conditions, the country’s market is anticipated to grow as STD incidence rises.

Global STD Diagnostics Market Outlook

The rising prevalence of STDs is the primary driver of the worldwide STD testing industry. STDs are caused by the transmission of various bacteria, viruses, and parasites through vaginal fluid exchange. Both men and women can be affected by STDs. Syphilis, gonorrhoea, chlamydia, hepatitis B, genital herpes, and HIV/AIDS are examples of STDs. HPV and Trichomoniasis vaginalis can also cause STDs. Syphilis, gonorrhoea, chlamydia, and trichomoniasis are treatable, but hepatitis B, genital herpes, HIV/AIDS, and HPV-related STDs are not. There have been continual innovations in the field of molecular diagnostics, which is one of the primary causes responsible for the expansion of STD diagnosis.

More product introductions are allowing laboratories to install instruments or equipment as needed. For example, Qiagen Inc. received European Commission clearance in May 2022 to produce Neu-MoDxHSV 1/2 Quant Assay for the measurement and distinction of herpes simplex virus type 1 (HSV-1) DNA and/or herpes simplex virus type 2 (HSV-2). The lack of healthcare services in developing countries is a major hindrance to the global STD testing market’s progress. A significant section of the population in growing nations such as Asia, the Middle East, and North Africa lacks adequate health information and access to proper healthcare services. This propensity is exacerbated by a lack of financial and human resources for medical treatment, which is a significant hindrance to public health promotion and adds to a large HIV-infected population.

Proactive healthcare is being promoted by increased awareness of the significance of rou-tine STD evaluations. According to estimates from the World Health Organisation (WHO), over 311,000 cervical cancer deaths occur yearly as a consequence of human papillomavirus (HPV) infection. Healthcare authorities, governments, and non-profit organizations have prioritized STD prevention and control due to the increasing burden. This has led to an ideal environment for the expansion of the STD diagnosis industry. For instance, the National Health Service (NHS) in the United Kingdom and the Centres for Disease Control and Pre-vention (CDC) in the United States have placed extensive programs to inform the public and promote routine STD screening.

Global STD Diagnostics Market Segmentation Analysis

The Global STD Diagnostics Market is segmented on the basis of Type, Location of Test, Devices Type, End-User, and Geography.

STD Diagnostics Market, By Type

• Chlamydia Testing
• Gonorrhoea Testing
• Syphilis Testing
• Human Papillomavirus (HPV) Testing
• Human Immunodeficiency Viruses (HIV) Testing
• Herpes Simplex Virus (HSV) Testing
• Human papillomavirus (HPV)
• Trichomonas Vaginalis (TV) Testing

To Get a Summarized Market Report By Type-

Based on Type, the market is segmented into Chlamydia Testing, Gonorrhea Testing, Syphilis Testing, Human Papillomavirus (HPV) Testing, Human Immunodeficiency Viruses (HIV) Testing, Herpes Simplex Virus (HSV) Testing, and Trichomonas Vaginalis (TV) Testing. Chlamydia Testing accounted for the largest market share of 31.37% in 2022 and is projected to grow at a CAGR of 5.69% during the forecast period. The bacteria that cause chlamydia, a sexually transmitted illness (STI), are identified using a chlamydia test. It is frequently asymptomatic and can infect both men and women. Nucleic acid amplification tests are a standard method to test for chlamydia (NAATs). Molecular tests known as NAATs are compassionate and specific tools for identifying the genetic material of the Chlamydia trachomatis bacteria. Urine, vaginal, penile, and rectal swabs are among the samples that can be used for these testing. Because urine samples are non-invasive, NAATs are especially useful for screening. Routine STI screening programs frequently include chlamydia testing, particularly for those who are more at risk, such as young adults who are sexually active, pregnant women, and those who have many sexual partners.

STD Diagnostics Market, By Location of Test

• Laboratory Tests
• Point of Care Tests

Based on Location of Test, the market is segmented into Laboratory Tests and Point of Care Tests. Laboratory Tests accounted for the largest market share of 76.26% in 2022 and is projected to grow at a CAGR of 7.19% during the forecast period. The diagnosis and treatment of sexually transmitted diseases (STDs) depend significantly on laboratory testing. Different laboratory procedures are utilized to diagnose sexually transmitted diseases (STDs); each has a unique application for accuracy, specificity, and productivity. Flow Cytometry analyses several biological indicators simultaneously, which helps discover co-infections. Applying flow cytometry for research to comprehend the immunology of sexually transmitted diseases is beneficial. Moreover, several pathogens can be detected by PCR in a single test, offering a thorough evaluation of the infection state.

STD Diagnostics Market, By Devices Type

• Thermal Cyclers – PCR
• Lateral Flow Readers Immunochromatographic Assays
• Flow Cytometers
• Enzyme Linked Immunosorbent Assay (ELISA)
• Point Of Care (PoC) Devices
• Phone Chips (Microfluidics + ICT)
• Porta-ble/Bench Top/Rapid Diagnostic Kits
• Others

Based on Devices Type, the market is segmented into Thermal Cyclers – PCR, Lateral Flow Readers Immunochromatographic Assays, Flow Cytometers, Enzyme Linked Immunosorbent Assay (ELISA), Point Of Care (PoC) Devices, Phone Chips (Microfluidics + ICT), Porta-ble/Bench Top/Rapid Diagnostic Kits, Others. Thermal Cyclers – PCR accounted for the largest market share of 43.98% in 2022 and is projected to grow at a CAGR of 6.78% during the forecast period. Thermal cyclers are sometimes called PCR (Polymerase Chain Reaction) equipment. The process of PCR is employed to diagnose sexually transmitted diseases (STDs) by amplifying DNA or RNA from pathogens, such as bacteria or viruses. The three primary phases of PCR—denaturation, annealing, and extension—require temperature cycling, which is accomplished significantly with thermal cyclers. Because PCR is so accurate, it may identify infections in miserable quantities, which is essential for early STD diagnosis. This sensitivity is especially crucial when treating STDs since the virus may initially present in low proportions.

STD Diagnostics Market, By End-User

• Hospitals & Clinics
• Diagnostics Centers
• Government Organizations

Based on End-User, the market is segmented into Hospitals & Clinics, Diagnostics Centers, and Government Organizations. Hospitals & Clinics accounted for the largest market share of 55.77% in 2022 and are projected to grow at a CAGR of 7.12% during the forecast period. Hospitals and clinics provide STD-related counseling and educational services alongside the diagnosis. Healthcare providers offer advice on safe procedures, infection prevention, and the possible implications of leaving infections undiagnosed. Counseling sessions provide a supportive atmosphere for patients to manage the problems associated with sexually transmitted illnesses by addressing the emotional and psychological components of living with an STD.

STD Diagnostics Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

To Get a Summarized Market Report By Geography-

On the basis of Geography, The Global STD Diagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest market share of 38.27% in 2022 and is projected to grow at a CAGR of 6.93% during the forecast period. Due to the high prevalence of STDs in the region, North America leads the world market for the diagnosis of sexually transmitted illnesses. Because of the high number of diagnostic firms and increased awareness of diseases, the United States is anticipated to be the largest market in the North American area. The Centers for Disease Control and Prevention (CDC) released a report in April 2022 titled “Sexually Transmitted Disease Surveillance, 2020” which indicated that STDs continue to be a major public health concern in the nation.

Europe was the second-largest market in 2022, and it is projected to grow at a CAGR of 7.25%. The increased public awareness and patient education are driving the growth of the sexually transmitted diseases (STD) diagnostics market. Furthermore, an increase in the number of education programs and government initiatives would fuel the demand for STD diagnostics. STD prevalence and incidence have skyrocketed in the last decade. Several countries around the world are focusing heavily on implementing nationwide screening programs to increase STD diagnosis coverage. Furthermore, reimbursement policies for STD services have benefited patients, which is contributing significantly to the growth of the STD testing market.

Key Players

The “Global STD Diagnostics Market” study report will provide valuable insight emphasizing the global market. The major players in the market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, BIOMÉRIEUX, Bio-Rad Laboratories, Inc., Danaher, DiaSorin S.p.A., QuidelOrtho Corporation, Hologic, Inc., OraSure Technologies, Siemens, Illumina Inc., See-gene Inc., Qiagen, MedMira Inc., and Cepheid. This section provides a company overview, ranking analysis, company regional and industry footprint, and ACE Matrix.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

• In February 2022, Lupin Limited, a Mumbai-based Indian Pharmaceutical firm- received approval from the U.S. FDA for the use of its antibiotic Solosec for treating sexually transmitted infections referred to as trichomoniasis and vaginal infection termed as bacterial vaginosis in women.
• In February 2022, Trinity Biotech, a Medical Laboratory Company based in Ireland & specializing in the production and marketing of clinically diagnostic products- has got the approval of the WHO for HIV screening tests.

Company Regional Footprint

The company’s regional section provides geographical presence, regional level reach, or the respective company’s sales network presence. For instance, F. Hoffmann-La Roche Ltd has its presence globally i.e. in North America, Europe, Asia Pacific and RoW. All the companies considered for profiling are reviewed similarly under this section. These sections help us to understand the overall STD Diagnostics Market presence on a global and country level.

Ace Matrix

This section of the report provides an overview of the company evaluation scenario in the STD Diagnostics Market. The company evaluation has been carried out based on the outcomes of the qualitative and quantitative analyses of various factors such as the product portfolios, technological innovations, market presence, revenues of companies, and the opinions of primary respondents.